BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9349896)

  • 1. Computer-assisted discrimination of glioblastomas.
    Scarpelli M; Montironi R; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
    Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
    Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometrically assisted grading of astrocytomas.
    Scarpelli M; Bartels PH; Montironi R; Galluzzi CM; Thompson D
    Anal Quant Cytol Histol; 1994 Oct; 16(5):351-6. PubMed ID: 7840841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
    Nafe R; Van de Nes J; Yan B; Schlote W
    Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time quantification of the proliferative state in astrocytomas.
    Ricco R; Cimmino A; Renzulli G; Serio G; Lozupone A; Lettini T; Pece A; Giardina C; Delfino VP
    Anal Quant Cytol Histol; 2000 Jun; 22(3):213-7. PubMed ID: 10872037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topometric analysis of diffuse astrocytomas.
    Nafe R; Schlote W
    Anal Quant Cytol Histol; 2003 Feb; 25(1):12-8. PubMed ID: 12630077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.
    Decaestecker C; Camby I; Gordower L; Dewitte O; Cras P; Martin JJ; Pasteels JL; Van Ham P; Brotchi J; Kiss R; Salmon I
    J Neuropathol Exp Neurol; 1998 Aug; 57(8):791-802. PubMed ID: 9720494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
    Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
    Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables.
    Decaestecker C; Salmon I; Dewitte O; Camby I; Van Ham P; Pasteels JL; Brotchi J; Kiss R
    J Neurosurg; 1997 Mar; 86(3):532-7. PubMed ID: 9046312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of astrocytomas and malignant astrocytomas by principal components analysis and a neural net.
    McKeown MJ; Ramsay DA
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1238-45. PubMed ID: 8957447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative index in astrocytic tumours.
    Rathi KR; Radotra BD; Khosla VK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosis.
    Scarpelli M; Montironi R; Magi Galluzzi C; Diamanti L
    Clin Neuropathol; 1994; 13(6):323-8. PubMed ID: 7851047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphometry of tumour cell nuclei in astrocytomas using shape analysis, densitometry and topometric analysis.
    Nafe R; Schlote W; Schneider B
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):34-44. PubMed ID: 15634229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.
    Decaestecker C; Camby I; Nagy N; Brotchi J; Kiss R; Salmon I
    Brain Pathol; 1998 Jan; 8(1):29-38. PubMed ID: 9458164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
    Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
    Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical grading of astrocytomas.
    Schad LR; Schmitt HP; Oberwittler C; Lorenz WJ
    Med Inform (Lond); 1987; 12(1):11-22. PubMed ID: 3035294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.